Hamit Uslu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Hamit Uslu has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Gözde Atila Uslu
Department of Physiology, Faculty of Medicine, Erzincan Binali Yıldırım University
10 shared publications - Taha Abdulkadir Coban
Department of Biochemistry, Faculty of Medicine, Erzincan Binali Yildirim University, Erzincan 24100, Türkiye
8 shared publications - Mustafa Özkaraca
Department of Pathology, Faculty of Veterinary Medicine, Sivas Cumhuriyet University, Sivas 58000, Turkey
7 shared publications - Ali Sefa Mendil
Department of Pathology, Faculty of Veterinary Medicine, Erciyes University, Kayseri, Turkey
6 shared publications - Serpil Aygörmez
Department of Biochemistry, Faculty of Veterinary Medicine, Kafkas University, Kars, Turkey
3 shared publications - Emine Toraman
Atatürk University, Science Faculty, Department of Molecular Biology and Genetics, Erzurum, Turkey
2 shared publications
Latest Publications
- 8 September 2026
- Published by Taylor & Francis in Drug and Chemical Toxicology
- Vol. 49 (6) , 1642-1653
Insights into the protective role of trigonelline in 5-fluorouracil–induced lung injury: targeting oxidative stress, inflammation, and apoptosis
- 8 September 2026
- Published by Taylor & Francis in Drug and Chemical Toxicology
- Vol. 49 (6) , 1642-1653
Insights into the protective role of trigonelline in 5-fluorouracil–induced lung injury: targeting oxidative stress, inflammation, and apoptosis
- Open Access
- 30 July 2026
- Published by Wiley in Journal of Biochemical and Molecular Toxicology
- Vol. 40 (8) , e71028
Apigenin, Selenium, and Combinations Are Effective in Preventing 5‐Fluorouracil Induced Cardiovascular Damage
Although chemotherapy is still a widely used primary treatment modality for many cancers, it is an accepted fact that it causes many undesirable side effects and toxicity. Until a new, side‐effect‐free treatment modality is developed, new resources will continue to be sought to prevent and reduce the adverse effects of chemotherapy. In this study, we investigated the potential of apigenin, selenium, and their combination to prevent cardiovascular toxicity induced by 5‐fluorouracil (5FU), an important chemotherapeutic agent. The study consisted of control (C), 5FU, apigenin + 5FU (Api + 5FU), selenium + 5FU (Se + 5FU), and apigenin + selenium + 5FU (Api + Se + 5FU) groups. Api (50 mg/kg) and Se (0.5 mg/kg) were administered orally to rats for 7 days. On Day 5, 5FU was administered i.p. at a dose of 150 mg/kg. Administration of 5FU significantly reduced GSH levels and CAT and TrxR activities in both cardiac and thoracic aortic tissues. It also decreased Bcl‐2 expression and increased Bax and Caspase‐3 expression in cardiac tissue, while reducing Bcl‐2 and increasing Bax expression in the thoracic aorta. Thoracic aortic MDA levels were also significantly elevated. On the contrary, oxidative stress and apoptosis were significantly decreased, and cardiovascular damage was attenuated in apigenin and selenium treated groups. In this study, it was determined that 5FU caused a higher level of toxicity to the heart compared to the thoracic aorta. In addition, both apigenin and selenium were shown to have significant protective effects on the cardiovascular system against 5FU toxicity. However, the cardiovascular protection against 5FU toxicity was found to be higher when apigenin and selenium were used together.
- 30 July 2026
- Published by Wiley in Journal of Biochemical and Molecular Toxicology
- Vol. 40 (8) , e71028
Open AccessApigenin, Selenium, and Combinations Are Effective in Preventing 5‐Fluorouracil Induced Cardiovascular Damage
Although chemotherapy is still a widely used primary treatment modality for many cancers, it is an accepted fact that it causes many undesirable side effects and toxicity. Until a new, side‐effect‐free treatment modality is developed, new resources will continue to be sought to prevent and reduce the adverse effects of chemotherapy. In this study, we investigated the potential of apigenin, selenium, and their combination to prevent cardiovascular toxicity induced by 5‐fluorouracil (5FU), an important chemotherapeutic agent. The study consisted of control (C), 5FU, apigenin + 5FU (Api + 5FU), selenium + 5FU (Se + 5FU), and apigenin + selenium + 5FU (Api + Se + 5FU) groups. Api (50 mg/kg) and Se (0.5 mg/kg) were administered orally to rats for 7 days. On Day 5, 5FU was administered i.p. at a dose of 150 mg/kg. Administration of 5FU significantly reduced GSH levels and CAT and TrxR activities in both cardiac and thoracic aortic tissues. It also decreased Bcl‐2 expression and increased Bax and Caspase‐3 expression in cardiac tissue, while reducing Bcl‐2 and increasing Bax expression in the thoracic aorta. Thoracic aortic MDA levels were also significantly elevated. On the contrary, oxidative stress and apoptosis were significantly decreased, and cardiovascular damage was attenuated in apigenin and selenium treated groups. In this study, it was determined that 5FU caused a higher level of toxicity to the heart compared to the thoracic aorta. In addition, both apigenin and selenium were shown to have significant protective effects on the cardiovascular system against 5FU toxicity. However, the cardiovascular protection against 5FU toxicity was found to be higher when apigenin and selenium were used together.
- Open Access
- 6 March 2026
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 399 (8) , 12799-12800
Correction: Nobiletin reduces 5-FU-induced lung injury with antioxidative, anti-inflammatory and anti-apoptotic activities
- 6 March 2026
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 399 (8) , 12799-12800
Open AccessCorrection: Nobiletin reduces 5-FU-induced lung injury with antioxidative, anti-inflammatory and anti-apoptotic activities
- 8 August 2025
- Published by Taylor & Francis in Drug and Chemical Toxicology
- Vol. 49 (1) , 90-99
Identification of the chemical constituents of Juglans regia ethanol extract by L-MS/MS and its effects on 5-FU-induced autophagy, oxidative stress, and apoptosis
5-fluorouracil (5-FU) is an important chemotherapeutic agent that has been used alone or in combination with other chemotherapeutics for years in the treatment of various malignancies. However, as with other chemotherapeutic agents, the disadvantage of 5-FU is that it damages healthy cells as well as cancer cells. Natural compounds are the first option that comes to mind to reduce and/or prevent undesirable side effects of chemotherapeutics. In this study, we aimed to determine the effects of Juglans regia extract (JR), whose antioxidant, anti-inflammatory, anti-diabetic, and antimicrobial effects were previously determined, on 5-FU-induced autophagy, oxidative stress, and apoptosis after its constituents were determined by LC-MS/MS. Experimental groups were formed as Control (C), JR, 5-FU, and JR + 5-FU. Rats were pretreated with JR at a dose of 200 mg/kg for seven days, and on the eighth day, a single dose of 100 mg/kg 5-FU was administered intraperitoneally to the JR + 5-FU and 5-FU groups. 5-FU disturbed the oxidant-antioxidant balance by increasing Keap1, TOS, and 8-OHdG levels and decreasing TAS levels and triggered cellular autophagy and apoptosis by increasing LC3B, Bax, and Caspase-3 levels and decreasing Bcl-2. JR pretreatment was shown to have modulating effects on the Keap1/Nrf2 pathway in the reorganization of the oxidant-antioxidant balance, to show anti-apoptotic activity, and to partially alleviate autophagy. JR's bioactive components were shown to alleviate oxidative stress and associated DNA damage via Keap1/Nrf2 and also attenuate fluorouracil-induced kidney damage by reducing autophagy and apoptosis, two important forms of programmed cell death, and have a promising potential against nephrotoxicity.
- 8 August 2025
- Published by Taylor & Francis in Drug and Chemical Toxicology
- Vol. 49 (1) , 90-99
Identification of the chemical constituents of Juglans regia ethanol extract by L-MS/MS and its effects on 5-FU-induced autophagy, oxidative stress, and apoptosis
5-fluorouracil (5-FU) is an important chemotherapeutic agent that has been used alone or in combination with other chemotherapeutics for years in the treatment of various malignancies. However, as with other chemotherapeutic agents, the disadvantage of 5-FU is that it damages healthy cells as well as cancer cells. Natural compounds are the first option that comes to mind to reduce and/or prevent undesirable side effects of chemotherapeutics. In this study, we aimed to determine the effects of Juglans regia extract (JR), whose antioxidant, anti-inflammatory, anti-diabetic, and antimicrobial effects were previously determined, on 5-FU-induced autophagy, oxidative stress, and apoptosis after its constituents were determined by LC-MS/MS. Experimental groups were formed as Control (C), JR, 5-FU, and JR + 5-FU. Rats were pretreated with JR at a dose of 200 mg/kg for seven days, and on the eighth day, a single dose of 100 mg/kg 5-FU was administered intraperitoneally to the JR + 5-FU and 5-FU groups. 5-FU disturbed the oxidant-antioxidant balance by increasing Keap1, TOS, and 8-OHdG levels and decreasing TAS levels and triggered cellular autophagy and apoptosis by increasing LC3B, Bax, and Caspase-3 levels and decreasing Bcl-2. JR pretreatment was shown to have modulating effects on the Keap1/Nrf2 pathway in the reorganization of the oxidant-antioxidant balance, to show anti-apoptotic activity, and to partially alleviate autophagy. JR's bioactive components were shown to alleviate oxidative stress and associated DNA damage via Keap1/Nrf2 and also attenuate fluorouracil-induced kidney damage by reducing autophagy and apoptosis, two important forms of programmed cell death, and have a promising potential against nephrotoxicity.
- 14 July 2025
- Published by Taylor & Francis in Archives of Physiology and Biochemistry
- Vol. 132 (1) , 12-26
Effects of apigenin, hesperidin and their combinations on different physiopathological pathways in 5-fluorouracil-induced pulmonary damage
Chemotherapeutics target cancerous cells, but they also have unavoidable toxicities in healthy tissues. In this study, the effects of the commonly used chemotherapeutic 5-fluorouracil (5FU) on lung tissue were investigated, along with the possible protective benefits of apigenin (API), hesperidin (HES), and their combination. The study consisted of control, 5FU, API + 5FU, HES + 5FU, and API+HES + 5FU groups. API 50 mg/kg and HES 200 mg/kg were administered for 7 days. On the 8th day, 5FU was administered a dose of 100 mg/kg. Analyses showed that API and HES were effective in preventing oxidative stress induced by 5FU in lung tissue, attenuating inflammation and apoptosis by suppressing MAPK/NFκB and Caspase-3/Bax/Bcl-2 pathways, suppressing autophagy by decreasing LC3B expression, and regulating Sigmar1 expression. These results suggest that the two flavonoids, when administered separately or in combination, may be useful in reducing side effects that often occur during the use of chemotherapeutics.
- 14 July 2025
- Published by Taylor & Francis in Archives of Physiology and Biochemistry
- Vol. 132 (1) , 12-26
Effects of apigenin, hesperidin and their combinations on different physiopathological pathways in 5-fluorouracil-induced pulmonary damage
Chemotherapeutics target cancerous cells, but they also have unavoidable toxicities in healthy tissues. In this study, the effects of the commonly used chemotherapeutic 5-fluorouracil (5FU) on lung tissue were investigated, along with the possible protective benefits of apigenin (API), hesperidin (HES), and their combination. The study consisted of control, 5FU, API + 5FU, HES + 5FU, and API+HES + 5FU groups. API 50 mg/kg and HES 200 mg/kg were administered for 7 days. On the 8th day, 5FU was administered a dose of 100 mg/kg. Analyses showed that API and HES were effective in preventing oxidative stress induced by 5FU in lung tissue, attenuating inflammation and apoptosis by suppressing MAPK/NFκB and Caspase-3/Bax/Bcl-2 pathways, suppressing autophagy by decreasing LC3B expression, and regulating Sigmar1 expression. These results suggest that the two flavonoids, when administered separately or in combination, may be useful in reducing side effects that often occur during the use of chemotherapeutics.
- 30 May 2025
- Published by Wiley in Chemistry & Biodiversity
- p. e00798
Hepatoprotective Activity of Prunus laurocerasus Fruit Extract Against 5‐FU‐Induced Liver Injury and LC‐MS/MS Profiling
5‐Fluorouracil (5‐FU), one of the most widely used chemotherapy drugs, is known to cause widespread toxicity and irreparable tissue damage. The purpose of this work was to analyze the phytochemical components of Prunus laurocerasus (PL) fruit extract using liquid chromatography with tandem mass spectrometry (LC‐MS/MS) and to look into the effectiveness of PL pretreatment on 5‐FU‐induced liver damage. The study consisted of control (C), PL, 5‐FU, PL+5‐FU groups, and PL groups received 500 mg/kg PL as pretreatment for seven days. On the eighth day, 100 mg/kg 5‐FU was administered intraperitoneally as a single dose to the PL+5‐FU and 5‐FU groups. In the LC‐MS/MS results, it was determined that the phenolic compounds found in the foreground in PL were quinic acid and chlorogenic acid. PL pretreatment increased total antioxidant status levels and B‐cell lymphoma 2 (Bcl‐2) expression and also decreased Keap1, total oxidant status, oxidative stress index levels, and Bcl‐2‐associated X protein, Caspase‐3, and light chain‐3B expressions. 8‐hydroxy‐2'‐deoxyguanosine levels were higher in the 5‐FU group compared to the C and PL groups. Moreover, in the PL+5‐FU group, the levels were similar to the C, PL, and 5‐FU groups. In conclusion, PL pretreatment demonstrated hepatoprotective action via regulating the Kelch‐like ECH‐associated protein 1/nuclear factor‐erythroid 2‐related factor 2 pathway in 5‐FU‐induced liver damage, lowering oxidative stress, and decreasing apoptosis and autophagy from programmed cell death.
- 30 May 2025
- Published by Wiley in Chemistry & Biodiversity
- p. e00798
Hepatoprotective Activity of Prunus laurocerasus Fruit Extract Against 5‐FU‐Induced Liver Injury and LC‐MS/MS Profiling
5‐Fluorouracil (5‐FU), one of the most widely used chemotherapy drugs, is known to cause widespread toxicity and irreparable tissue damage. The purpose of this work was to analyze the phytochemical components of Prunus laurocerasus (PL) fruit extract using liquid chromatography with tandem mass spectrometry (LC‐MS/MS) and to look into the effectiveness of PL pretreatment on 5‐FU‐induced liver damage. The study consisted of control (C), PL, 5‐FU, PL+5‐FU groups, and PL groups received 500 mg/kg PL as pretreatment for seven days. On the eighth day, 100 mg/kg 5‐FU was administered intraperitoneally as a single dose to the PL+5‐FU and 5‐FU groups. In the LC‐MS/MS results, it was determined that the phenolic compounds found in the foreground in PL were quinic acid and chlorogenic acid. PL pretreatment increased total antioxidant status levels and B‐cell lymphoma 2 (Bcl‐2) expression and also decreased Keap1, total oxidant status, oxidative stress index levels, and Bcl‐2‐associated X protein, Caspase‐3, and light chain‐3B expressions. 8‐hydroxy‐2'‐deoxyguanosine levels were higher in the 5‐FU group compared to the C and PL groups. Moreover, in the PL+5‐FU group, the levels were similar to the C, PL, and 5‐FU groups. In conclusion, PL pretreatment demonstrated hepatoprotective action via regulating the Kelch‐like ECH‐associated protein 1/nuclear factor‐erythroid 2‐related factor 2 pathway in 5‐FU‐induced liver damage, lowering oxidative stress, and decreasing apoptosis and autophagy from programmed cell death.
- 26 May 2025
- Published by Springer Nature in Journal of Molecular Histology
- Vol. 56 (3) , 1-14
Biochemical and histopathological changes in ovary, uterus and testicular tissues after acrylamide exposure
Acrylamide (ACR) is a popular substance to which our exposure increases with the changes in our lifestyle and brings with it various health problems. In order to determine appropriate therapeutics against ACR damage, it is important to investigate the multiple mechanisms that may be effective in its pathophysiology. This study investigated the effects of ACR exposure on ovarian, uterine, and testicular tissues by considering different pathophysiological pathways. Male-control (MC), male-acrylamide (MACR), female-control (FC), and female-acrylamide (FACR) groups were formed. ACR was administered at a dose of 60 mg/kg for 5 days. ACR exposure decreased CAT and TrxR-specific activities, GSH levels, and Bcl-2 expression, while significantly increasing MDA, IL-6, and NFĸB p65 levels, caspase 3, and Bax expression in ovarian, uterine, and testicular tissues. Based on these results, it was determined that acrylamide induced damage in ovarian, uterine and testicular tissues through various pathways such as oxidative stress, inflammation, and apoptosis. Consequently, when selecting a therapeutic target, the substance whose efficacy is being investigated should be effective in these pathways. Furthermore, this study is the first to demonstrate the occurrence of bladder retention in both sexes following acrylamide exposure and will be an important step for future research. Graphical abstract
- 26 May 2025
- Published by Springer Nature in Journal of Molecular Histology
- Vol. 56 (3) , 1-14
Biochemical and histopathological changes in ovary, uterus and testicular tissues after acrylamide exposure
Acrylamide (ACR) is a popular substance to which our exposure increases with the changes in our lifestyle and brings with it various health problems. In order to determine appropriate therapeutics against ACR damage, it is important to investigate the multiple mechanisms that may be effective in its pathophysiology. This study investigated the effects of ACR exposure on ovarian, uterine, and testicular tissues by considering different pathophysiological pathways. Male-control (MC), male-acrylamide (MACR), female-control (FC), and female-acrylamide (FACR) groups were formed. ACR was administered at a dose of 60 mg/kg for 5 days. ACR exposure decreased CAT and TrxR-specific activities, GSH levels, and Bcl-2 expression, while significantly increasing MDA, IL-6, and NFĸB p65 levels, caspase 3, and Bax expression in ovarian, uterine, and testicular tissues. Based on these results, it was determined that acrylamide induced damage in ovarian, uterine and testicular tissues through various pathways such as oxidative stress, inflammation, and apoptosis. Consequently, when selecting a therapeutic target, the substance whose efficacy is being investigated should be effective in these pathways. Furthermore, this study is the first to demonstrate the occurrence of bladder retention in both sexes following acrylamide exposure and will be an important step for future research. Graphical abstract
- Open Access
- 17 January 2025
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 398 (7) , 8543-8554
Nobiletin reduces 5-FU-induced lung injury with antioxidative, anti-inflammatory and anti-apoptotic activities
Like other chemotherapeutic agents, 5-fluorouracil (5-FU) targets cancerous cells, but it also causes many unwanted side effects on healthy tissues and cells. Based on the undesirable effects of 5-FU, the aim of this study was to determine how 5-FU affects lung tissue and whether nobiletin has any protective effect. The study consisted of negative control, Nobiletin, 5-FU and Nobiletin + 5-FU groups. Nobiletin and Nobiletin + 5-FU groups received 10 mg/kg Nobiletin i.g. for 7 days. On day 8, 100 mg/kg 5-FU was administered i.p. to 5-FU and Nobiletin + 5-FU groups. Biochemical and immunohistochemical analyses were performed on the lung tissues dissected at the end of the study. 5-FU caused growth retardation, disturbed the oxidant-antioxidant balance by increasing MDA levels and decreasing GSH levels, triggered cellular apoptosis by increasing Bax and caspase-3 levels and decreasing Bcl-2, also increased lung tissue inflammation and damage by increasing NFκB and IL-1β levels. However, it was determined that Nobiletin prevented the disruption of the oxidant-antioxidant balance, showed significant anti-apoptotic effects, especially by reducing Bax levels and partially modulating caspase-3 and Bcl-2 levels, and also exhibited anti-inflammatory effects by reducing NFκB and IL-1β levels and supported the normal development of animals. Our results showed that nobiletin pretreatment showed anti-inflammatory activity by inhibiting the NFκB pathway in 5-FU-induced lung injury, suppressed oxidative stress with its antioxidant activity and was effective in modulating cellular apoptosis with its anti-apoptotic activity. In conclusion, Nobiletin has been shown to have an important potential in reducing fluorouracil-induced tissue damage by acting through multiple pathways. Graphical Abstract
- 17 January 2025
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 398 (7) , 8543-8554
Open AccessNobiletin reduces 5-FU-induced lung injury with antioxidative, anti-inflammatory and anti-apoptotic activities
Like other chemotherapeutic agents, 5-fluorouracil (5-FU) targets cancerous cells, but it also causes many unwanted side effects on healthy tissues and cells. Based on the undesirable effects of 5-FU, the aim of this study was to determine how 5-FU affects lung tissue and whether nobiletin has any protective effect. The study consisted of negative control, Nobiletin, 5-FU and Nobiletin + 5-FU groups. Nobiletin and Nobiletin + 5-FU groups received 10 mg/kg Nobiletin i.g. for 7 days. On day 8, 100 mg/kg 5-FU was administered i.p. to 5-FU and Nobiletin + 5-FU groups. Biochemical and immunohistochemical analyses were performed on the lung tissues dissected at the end of the study. 5-FU caused growth retardation, disturbed the oxidant-antioxidant balance by increasing MDA levels and decreasing GSH levels, triggered cellular apoptosis by increasing Bax and caspase-3 levels and decreasing Bcl-2, also increased lung tissue inflammation and damage by increasing NFκB and IL-1β levels. However, it was determined that Nobiletin prevented the disruption of the oxidant-antioxidant balance, showed significant anti-apoptotic effects, especially by reducing Bax levels and partially modulating caspase-3 and Bcl-2 levels, and also exhibited anti-inflammatory effects by reducing NFκB and IL-1β levels and supported the normal development of animals. Our results showed that nobiletin pretreatment showed anti-inflammatory activity by inhibiting the NFκB pathway in 5-FU-induced lung injury, suppressed oxidative stress with its antioxidant activity and was effective in modulating cellular apoptosis with its anti-apoptotic activity. In conclusion, Nobiletin has been shown to have an important potential in reducing fluorouracil-induced tissue damage by acting through multiple pathways. Graphical Abstract
- 26 August 2020
- Published by SDU Journal of Natural and Applied Sciences in SDÜ Fen Bilimleri Enstitüsü Dergisi
- Vol. 24 (2) , 317-322
Hyoscyamus reticulatus L. Tohum Ekstraktının Antimikrobiyal ve Apoptotik Etkinliğinin Araştırılması
Hyoscyamus reticulatus Solanacea ailesindendir ve ülkemizde altı türü bulunmaktadır. Hyoscyamus türleri özellikle halk arasında yaygın olarak kullanılan skopolamin ve hiyosiyamin gibi tropan alkaloitleri kaynağıdır. H. reticulatus tohumundan soxhlet yöntemi ile elde edilen etil alkol ekstresinin bazı Gram (-) ve Gram (+) bakteri ve mayalara karşı antimikrobiyal aktivitesinin tespit edilmesi ve H. reticulatus tohumunun plazma ve beyin numunelerinde TP53 ve Bcl-2 seviyeleri ölçülerek apoptotik etkisinin belirlenmesi amaçlanmıştır. Çalışmada 40 adet Wistar albino cinsi dişi sıçan her grupta 10 adet olacak şekilde 4 gruba ayrıldı; Kontrol (K), 125, 250, 500 mg/kg H. reticulatus ekstrakt grupları. H. reticulatus tohumu ekstraktının Bacillus subtilis, Escherichia coli, Klebsiella pneumoniae, Pasteurella multicoda, Pseudomonas aeruginosa, Salmonella enteridis, Staphylococcus aureus, Yersinia enterocolitica bakterileri ve Candida albicans mayasına karşı antimikrobiyal etkinliğinin bulunmadığı tespit edilmiştir. HR250 ve HR500 gruplarının plazma örneklerinde TP53 seviyelerinin K grubuna göre önemli düzeyde arttığı tespit edildi (sırasıyla p<0,01, p<0,001). Ekstrakt uygulanan tüm gruplarla K grubu karşılaştırıldığında; ekstrakt uygulanan gruplarda plazma Bcl-2 seviyelerinin önemli düzeyde azaldığı belirlendi (p<0,001). Sonuç olarak; H. reticulatus tohum ektraktının antimikrobiyal etkisi olmadığı ve in vivo olarak farklı dozlarda uygulanan ekstraktın beyin dokusunda olmasa da diğer organ ve/veya organlarda apoptozisi uyarabileceğini düşünmekteyiz.
- 26 August 2020
- Published by SDU Journal of Natural and Applied Sciences in SDÜ Fen Bilimleri Enstitüsü Dergisi
- Vol. 24 (2) , 317-322
Hyoscyamus reticulatus L. Tohum Ekstraktının Antimikrobiyal ve Apoptotik Etkinliğinin Araştırılması
Hyoscyamus reticulatus Solanacea ailesindendir ve ülkemizde altı türü bulunmaktadır. Hyoscyamus türleri özellikle halk arasında yaygın olarak kullanılan skopolamin ve hiyosiyamin gibi tropan alkaloitleri kaynağıdır. H. reticulatus tohumundan soxhlet yöntemi ile elde edilen etil alkol ekstresinin bazı Gram (-) ve Gram (+) bakteri ve mayalara karşı antimikrobiyal aktivitesinin tespit edilmesi ve H. reticulatus tohumunun plazma ve beyin numunelerinde TP53 ve Bcl-2 seviyeleri ölçülerek apoptotik etkisinin belirlenmesi amaçlanmıştır. Çalışmada 40 adet Wistar albino cinsi dişi sıçan her grupta 10 adet olacak şekilde 4 gruba ayrıldı; Kontrol (K), 125, 250, 500 mg/kg H. reticulatus ekstrakt grupları. H. reticulatus tohumu ekstraktının Bacillus subtilis, Escherichia coli, Klebsiella pneumoniae, Pasteurella multicoda, Pseudomonas aeruginosa, Salmonella enteridis, Staphylococcus aureus, Yersinia enterocolitica bakterileri ve Candida albicans mayasına karşı antimikrobiyal etkinliğinin bulunmadığı tespit edilmiştir. HR250 ve HR500 gruplarının plazma örneklerinde TP53 seviyelerinin K grubuna göre önemli düzeyde arttığı tespit edildi (sırasıyla p<0,01, p<0,001). Ekstrakt uygulanan tüm gruplarla K grubu karşılaştırıldığında; ekstrakt uygulanan gruplarda plazma Bcl-2 seviyelerinin önemli düzeyde azaldığı belirlendi (p<0,001). Sonuç olarak; H. reticulatus tohum ektraktının antimikrobiyal etkisi olmadığı ve in vivo olarak farklı dozlarda uygulanan ekstraktın beyin dokusunda olmasa da diğer organ ve/veya organlarda apoptozisi uyarabileceğini düşünmekteyiz.
- Open Access
- 30 May 2019
- Published by Biomedpress in Biomedical Research and Therapy
- Vol. 6 (5) , 3142-3150
Hepatoprotective and nephroprotective effects of Trigonella foenum-graecum L. (Fenugreek) seed extract against sodium nitrite toxicity in rats
Introduction: Feeding habits and environmental factors may rival genetic susceptibility as etiological factors related to various cancers. Humans are continuously exposed to many synthetic food additives, one of which is sodium nitrite (NaNO2). There is a direct correlation between increases in consumption of nitrite-treated products and incidence of tissue damage, hepatotoxicity, nephrotoxicity and some types of cancer. The objective of this study was to investigate the protective effects of Trigonella foenum-graecum (TFG) on NaNO2-induced hepatotoxicity and nephrotoxicity. Methods: Forty rats were randomly assigned (10 per group) to control (physiological saline solution), TFG (150 mg/kg/day), NaNO2 (80 mg/kg/day), and NaNO2+TFG (80 mg/kg/day + 150 mg/kg/day) groups. This group was offered TFG seed extract two hours before NaNO2. At the end of three months, the rats were decapitated, and blood, kidney and liver tissues were removed. Results: Three months of oral administration of NaNO2 increased serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), urea, creatinine, and pro-inflammatory cytokine levels in the liver and kidney tissues [except for liver Interleukin 1 alpha (IL-1a)] of rats. Serum AST, ALT, urea, creatinine, liver IL-6, and kidney tumor necrosis factor-a (TNF-a), IL-6, IL-1a levels significantly decreased in the NaNO2+TFG group compared to the NaNO2 group. Pathological examinations, it was determined show that exogenously administered TFG could alleviate the effects of NaNO2 hepatotoxicity and nephrotoxicity. Conclusions: Our results suggest that exogenous TFG mitigates NaNO2-administration induced hepatotoxicity and nephrotoxicity. TFG extract exerted antioxidative and anti-inflammatory effects, and played a significant role in preventing hepatic and renal damage induced by chronic NaNO2 administration.
- 30 May 2019
- Published by Biomedpress in Biomedical Research and Therapy
- Vol. 6 (5) , 3142-3150
Open AccessHepatoprotective and nephroprotective effects of Trigonella foenum-graecum L. (Fenugreek) seed extract against sodium nitrite toxicity in rats
Introduction: Feeding habits and environmental factors may rival genetic susceptibility as etiological factors related to various cancers. Humans are continuously exposed to many synthetic food additives, one of which is sodium nitrite (NaNO2). There is a direct correlation between increases in consumption of nitrite-treated products and incidence of tissue damage, hepatotoxicity, nephrotoxicity and some types of cancer. The objective of this study was to investigate the protective effects of Trigonella foenum-graecum (TFG) on NaNO2-induced hepatotoxicity and nephrotoxicity. Methods: Forty rats were randomly assigned (10 per group) to control (physiological saline solution), TFG (150 mg/kg/day), NaNO2 (80 mg/kg/day), and NaNO2+TFG (80 mg/kg/day + 150 mg/kg/day) groups. This group was offered TFG seed extract two hours before NaNO2. At the end of three months, the rats were decapitated, and blood, kidney and liver tissues were removed. Results: Three months of oral administration of NaNO2 increased serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), urea, creatinine, and pro-inflammatory cytokine levels in the liver and kidney tissues [except for liver Interleukin 1 alpha (IL-1a)] of rats. Serum AST, ALT, urea, creatinine, liver IL-6, and kidney tumor necrosis factor-a (TNF-a), IL-6, IL-1a levels significantly decreased in the NaNO2+TFG group compared to the NaNO2 group. Pathological examinations, it was determined show that exogenously administered TFG could alleviate the effects of NaNO2 hepatotoxicity and nephrotoxicity. Conclusions: Our results suggest that exogenous TFG mitigates NaNO2-administration induced hepatotoxicity and nephrotoxicity. TFG extract exerted antioxidative and anti-inflammatory effects, and played a significant role in preventing hepatic and renal damage induced by chronic NaNO2 administration.